Samsung Next invests in bold and ambitious founders, focusing on transformative innovations in AI, intelligent machines, healthtech, consumer services, and frontier technology.

CG Health Ventures provides investment and support to innovative start ups. We have a particular interest in the fields of Health IT, Digital Health and Genomics, where we look for projects that address real needs in attractive markets. We typically invest in the project early, sometimes even at concept stage. We look for entrepreneurs who have grand ambitions and will not give up easily on achieving their dreams. We believe in the importance of values fit; we want to work effectively together but also have fun along the way. We prioritize projects to which we can add value through our engagement, passion, experience and network, as we like to roll up our sleeves to support the entrepreneur throughout their journeys. We think global, but our network and experience is concentrated in Europe and the US.

Faster, easier, better diagnosis of infectious diseases.

Developer of artificial intelligence-based drug development data software designed to conduct patient-centric drug simulations to accelerate and de-risk drug development. The company's software combines data points from across the clinical and drug development spectrum and predicts patient response to both approved and novel therapies, allowing pharma and biotech customers to run variations of their clinical trials to improve the trial design and increase the probability of trial success, enabling healthcare industry in the discovery of new clinical opportunities and improve strategies.

Idonia es una compañía especializada en el desarrollo de soluciones software para el sector sanitario y servicios. Trabajamos para facilitar la integración de las imágenes médicas en los estándares que marcan las tecnologías de la información aplicadas a la salud, sin perder nunca el foco en nuestro objetivo: la satisfacción del paciente y de los profesionales que contribuyen en mejorar su calidad de vida.

Welcome to Switzerland’s leading launchpad for early stage healthtech ventures. We accelerate high-potential, early-stage ventures at the intersection of healthtech with the life science industry. DayOne is based in Basel – strategically positioned at the heart of Europe’s leading life sciences ecosystem. By providing a comprehensive support system and facilitating access to industry leaders, experienced mentors and a strong network of partners and investors in the life science sector, we help our portfolio companies overcome early-stage challenges, secure financing, and scale their innovations.

Galen Growth is the leading intelligence platform for digital health, purpose-built to help organisations navigate and win in an increasingly complex, data-saturated landscape. Our proprietary solution, HealthTech Alpha, combines GenAI-powered analytics with the industry’s most structured dataset to deliver targeted, clinically relevant insights instantly. Trusted by global pharma, investors, and health systems, we empower teams to accelerate decision-making, reduce risk, and focus their resources where they add the most strategic value. As GenAI redefines expectations for speed, efficiency, and precision, market intelligence is no exception. Galen Growth is at the forefront of this shift, enabling partners to modernise how they source, assess, and act on innovation opportunities. To learn more about our company and services, visit our website at www.galengrowth.com and follow this page for regular updates. To get started with HealthTech Alpha, visit healthechalpha.com to access our data platform and kickstart your next Digital Health solution.

INNITIUS is a Spanish Startup focused on Enhancing Diagnostics for Women’s Health. The company develops medical devices (Hardware + Software) which combines a novel technology (Torsional Waves) with Artificial Intelligence for the diagnosis of pathologies with an associated change in a woman’s cervical tissue consistency. The company, that was incorporated in 2018, is currently at the clinical evaluation stage, with the target of accessing the market by the end of 2022 with its first product: Fine Birth.

Este perfil esta inactivo. Si quieres enterarte de todas las novedades. Síguenos en el perfil de Vithas

Voloridge is a quantitative investment management firm built upon a foundation of collaboration. Our team includes award-winning researchers, skilled data analysts, cutting-edge technologists and financial professionals who understand that our success is due to the remarkable way we work together. Our team is made of relentless innovators on a quest to create value for our investors. We strive to operate at a high level of integrity and spend our days solving complex problems in a sophisticated quantitative environment. Our mission is to “Deliver superior risk-adjusted returns driven by an entrepreneurial environment that inspires unyielding passion, imagination, and commitment to excellence.”

Committed to providing 24x7 availability of world-class medical facilities backed by expertise and excellence. Upgrade your Healthcare experience with Aster Royal Al Raffah Hospital, Oman. https://www.aster.om/ 98550066

Bessemer Venture Partners helps entrepreneurs lay strong foundations to build and forge long-standing companies. With more than 145 IPOs and 300 portfolio companies in the enterprise, consumer and healthcare spaces, Bessemer supports founders and CEOs from their early days through every stage of growth. Bessemer’s global portfolio has included Pinterest, Shopify, Twilio, Yelp, LinkedIn, PagerDuty, DocuSign, Wix, Fiverr, and Toast and has more than $18 billion of assets under management. Bessemer has teams of investors and partners located in Tel Aviv, Silicon Valley, San Francisco, New York, London, Hong Kong, Boston, and Bangalore. Born from innovations in steel more than a century ago, Bessemer’s storied history has afforded its partners the opportunity to celebrate and scrutinize its best investment decisions (see Memos) and also learn from its mistakes (see Anti-Portfolio).

The Royal Society of Medicine is a leading provider of continuing learning to healthcare professionals. Our vision: better healthcare for better lives. If you have an interest in medicine and healthcare, want to connect with your community and access a raft of career and learning opportunities – then the RSM is for you.

CliniNote unlocks the power of clinical data with innovative tools for healthcare providers and the pharmaceutical industry. Our AI-Agents deliver real-time, high-quality, interoperable data to enhance research, drug development, market access, and patient care—all without burdening clinicians or altering existing workflows and hospital systems. Powered by AI and NLP, the CliniNote Assistant helps doctors create clinical notes while effortlessly capturing comprehensive data. This boosts efficiency and creates previously unavailable Real-World Data points without additional effort from medical professionals or changes to existing processes and systems. We automate data entry for #ClinicalTrials and support clinicians with prospective #AI and #NLP data creation, reducing burdens and enhancing #dataquality. Our commitment ensures the highest quality #RealWorldData collection. We collaborate with healthcare providers (#HCP), site management organizations (#SMO), the pharmaceutical industry, contract research organizations (#CRO), regulators, and healthcare system institutions (#HCS). Our mission is to introduce methods and tools that drastically improve the efficiency of working with clinical data, driving forward advancements in healthcare. #realworldevidence #realworlddata #healthcaredata #precisiononcology #NLP #ontology #datascience #dataanalytics #AI #machinelearning #decisionsupport #bigdata #analytics #AdvancedAnalytics #healthtech #innovation #digitalhealth

HealthCap is a general and professional liability insurance company owned and governed by the long term care providers we insure. HealthCap provides liability insurance products, risk management services, and accredited education to nursing homes, assisted living facilities, and continuing care retirement communities. There are three pillars to HealthCap's success: -Member Ownership -Risk Management -Claims Expertise HealthCap is owned and governed by its members, the senior care facilities that we insure. All profits accrue to the benefits of our members, with excess profits returned as dividends at the discretion of the board of directors. Since our formation in 2001, HealthCap has grown to become a top-3 liability insurance provider to the industry, with over 1,700 insured facilities. HealthCap has built significant financial strength, with more than $250 million in assets and more than $50 million in equity, one of the largest commitments in the insurance industry to senior care. HealthCap is rated "A (Exceptional)" by Demotech, Inc., meeting the insurance rating requirements of HUD.

Kilo Health is a leader in the digital health and wellness sector, with over 6,5 million customers worldwide. Since 2021, it was listed as the second fastest-growing company in Europe by Financial Times FT 1,000 and the second-fastest-growing company in Central Europe on the Deloitte Technology Fast 50 list. Kilo Health was also acknowledged by Verslo Žinios as the #1 Lithuanian company in the technology sector in 2022. Currently, the company has 600+ experts and offices across 5 European cities. Kilo Health’s portfolio contains over 30 innovative digital health products in chronic disease management, mental health improvement, and healthy habit change. The company also runs the startup accelerator Kilo Ventures, startup incubator Kilo Co-Found, upskilling program Kilo Academy, and offers its products to business clients. Since 2021, Kilo Health has been a member of the DTx Alliance, Matter Community, and HealthXL.

Manufacture of data center infrastructure solutions intended to enhance the operational capabilities of digital companies. The company specializes in privatized manufacturing of mission-critical equipment, delivering high-quality, tailored solutions designed to meet specific client needs at scale, enabling businesses to innovate effectively while benefiting from unmatched quality, support, and transparency in their infrastructure sourcing.

Aisthesis Medical is a MedTech startup revolutionizing acute and critical care with VIOSync, an AI-powered clinical decision-support system that predicts sepsis, hypotension, and multi-organ dysfunction before clinical deterioration occurs. By integrating EHRs, wearable devices, and bedside monitors, VIOSync creates a digital twin for each patient, providing real-time, explainable predictive analytics to enhance decision-making. Designed for seamless adoption, VIOSync not only detects risks early but also aligns with evidence-based protocols to guide interventions, improving patient outcomes, reducing ICU admissions, and streamlining hospital workflows. With a focus on high-risk, undermonitored settings, we are redefining how hospitals predict and manage critical conditions before they escalate.

Elaia is a full stack tech and deep tech investor. We partner with ambitious entrepreneurs from inception to leadership, helping them navigate the future and the unknown. For over twenty years, we have combined deep scientific and technological expertise with decades of operational experience to back those building tomorrow. Our joint venture with Lazard, Lazard Elaia Capital, enables us to support exceptional founders at any stage. From our offices in Paris, Barcelona and Tel Aviv, we have been active partners with over 100 startups including Criteo, Mirakl, Shift Technology, AQEMIA and Alice & Bob.

ZKN is de branchevereniging van klinieken in Nederland. We vertegenwoordigen ruim 130 leden met zo’n 420 locaties, dit is zo'n 60% van alle klinieken in Nederland. Onze leden hebben, om lid te kunnen worden, allemaal het ZKN-keurmerk behaald. Ze worden jaarlijks geaudit door een onafhankelijke auditor op o.a. kwaliteit en veiligheid. Een van onze belangrijkste taken is het behartigen van de kliniek belangen bij inspecties, ministeries, verzekeraars en andere belanghebbenden. Ook hebben we onze eigen cao en zijn leden automatisch aangesloten bij de onafhankelijke ZKN geschillencommissie. Onze klinieken leveren alle (planbare) medisch specialistische zorg. Veel klinieken focussen zich op één of enkele specialismen zoals oogheelkunde, dermatologie, orthopedie, heelkunde, plastische chirurgie of cardiologie. Je vind alle bij ZKN aangesloten leden op onze website.

Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs. Develops a line of diagnostic and therapeutic products for diabetics. Working towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to ''think outside the box''. Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.

AICURA is a leading data and AI company with a focus on healthcare and life sciences. With a mission to enhance patient outcomes, AICURA has built a secure and collaborative data and AI ecosystem. The AICURA platform simplifies the process of data aggregation, exploration, and curation, and leverages AI for automated data analysis and predictive models. AICURA connects various stakeholders, including biotech firms, healthcare providers, medtech companies, clinical researchers, and Contract Research Organizations (CROs), establishing a comprehensive network for data, technology, and knowledge transfer across the healthcare industry. This ecosystem accelerates scalable data-driven research, expedites and de-risks drug development, improves patient care, and fosters AI-based product innovation, paving the way for better treatment options for patients.

Clinica especializada en el diagnóstico del cáncer de piel y otras lesiones pigmentarias. Utilizamos equipos de diagnostico de última generación. Pioneros en el diagnóstico del cáncer. Con un equipo médico de reconocimiento mundial en lesiones pigmentarias, melanoma, carcinoma... Tambien tratamientos postoperacion, de rejuvenecimiento, dermocosmetica, melasma, hipersudoracion, vitaminas.

Investing in pre-seed startups with gender-diverse founding teams in ClimateTech, FemTech, HealthTech, FinTech & HR Tech

FormlyAI is medical device compliance made easy. Our AI powered software ensures medical device certification that is fast, affordable, and tailored to your needs. Reach out to us if you are interested in learning more!